SCHEMBL4927574

SCHEMBL4927574

Fc1cc2c(c(-c3ccccc3C(F)(F)F)c1)O[C@@H](CBr)CC2

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AQP1 P29972 3/20 0.37
NFKB1 P19838 2/20 0.35
NFKB2 Q00653 2/20 0.35
RELA Q04206 2/20 0.35
TRPA1 O75762 4/20 0.32
PIK3R1 P27986 1/20 0.32
PIK3CA P42336 1/20 0.32
CYP27A1 Q02318 1/20 0.32
CYP24A1 Q07973 1/20 0.32
TRPM8 Q7Z2W7 2/20 0.31
TRPV1 Q8NER1 2/20 0.31
HTR2A P28223 1/20 0.31
HTR2C P28335 1/20 0.31
USP2 O75604 2/20 0.31
CYP1A2 P05177 2/20 0.31
CYP3A4 P08684 2/20 0.31
CYP2D6 P10635 2/20 0.31
CYP2C19 P33261 2/20 0.31
MEN1 O00255 1/20 0.31
ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8211139 0.89 AQP1 (0.46) AQP1NFKB1NFKB2RELATRPA1
SCHEMBL4226266 0.80 AQP1 (0.59) AQP1TRPA1PIK3R1PIK3CATRPM8
SCHEMBL5323073 0.78 AQP1 (0.31) AQP1NFKB1NFKB2RELATRPA1
SCHEMBL8215359 0.78 AQP1 (0.48) AQP1PRKAB2PRKAG1PRKAA2PRKAA1
SCHEMBL8211141 0.78 AQP1 (0.43) AQP1NFKB1NFKB2RELAHTR2C
SCHEMBL8216108 0.77 AQP1 (0.40) AQP1NFKB1NFKB2RELATRPA1
SCHEMBL8210969 0.76 AQP1 (0.47) AQP1NFKB1NFKB2RELATSHR
SCHEMBL8202934 0.75 AQP1 (0.59) AQP1HTR2AHTR2CPRKAB2PRKAG1
SCHEMBL8215357 0.75 AQP1 (0.46) AQP1PRKAB2PRKAG1PRKAA2PRKAA1
SCHEMBL8203040 0.75 AQP1 (0.46) AQP1DRD2DRD4DRD3PRKAB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080039639-A1 Chromane and chromene derivatives and uses thereof WYETH (US) 2008-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080039639-A1 Chromane and chromene derivatives and uses thereof HTR1A, CHRM1, HTR2C AQP1 2983/4885NFKB1 4678/4885NFKB2 4090/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.